Effects of Human Leukocyte Antigen Class I Genetic Parameters on Clinical Outcomes and Survival after Initiation of Highly Active Antiretroviral Therapy | Zendy

Zabrina L. Brumme | Zendy; Chanson J. Brumme | Zendy; Celia Chui | Zendy; Theresa Mo | Zendy; Brian Wynhoven | Zendy; Conan K. Woods | Zendy; Bethany M. Henrick | Zendy; Robert S. Hogg | Zendy; Joan Montaner | Zendy; P. Richard Harrigan | Zendy

Open Access

Effects of Human Leukocyte Antigen Class I Genetic Parameters on Clinical Outcomes and Survival after Initiation of Highly Active Antiretroviral Therapy

Author(s) -

Zabrina L. Brumme,

Chanson J. Brumme,

Celia Chui,

Theresa Mo,

Brian Wynhoven,

Conan K. Woods,

Bethany M. Henrick,

Robert S. Hogg,

Joan Montaner,

P. Richard Harrigan

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/516789

Subject(s) - human leukocyte antigen , immunology , viral load , proportional hazards model , survival analysis , medicine , biology , antigen , virus

Human leukocyte antigen (HLA) class I variation influences the progression of untreated human immunodeficiency virus (HIV) disease; however, it is not known whether HLA class I variation may influence clinical outcomes after initiation of highly active antiretroviral therapy (HAART).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research